Literature DB >> 17785179

Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.

Guillaume Lucas1, Vladimir V Rymar, Jenny Du, Ouissame Mnie-Filali, Christina Bisgaard, Stella Manta, Laura Lambas-Senas, Ove Wiborg, Nasser Haddjeri, Graciela Piñeyro, Abbas F Sadikot, Guy Debonnel.   

Abstract

Current antidepressants are clinically effective only after several weeks of administration. Here, we show that serotonin(4) (5-HT(4)) agonists reduce immobility in the forced swimming test, displaying an antidepressant potential. Moreover, a 3 day regimen with such compounds modifies rat brain parameters considered to be key markers of antidepressant action, but that are observed only after 2-3 week treatments with classical molecules: desensitization of 5-HT(1A) autoreceptors, increased tonus on hippocampal postsynaptic 5-HT(1A) receptors, and enhanced phosphorylation of the CREB protein and neurogenesis in the hippocampus. In contrast, a 3 day treatment with the SSRI citalopram remains devoid of any effect on these parameters. Finally, a 3 day regimen with the 5-HT(4) agonist RS 67333 was sufficient to reduce both the hyperlocomotion induced by olfactory bulbectomy and the diminution of sucrose intake consecutive to a chronic mild stress. These findings point out 5-HT(4) receptor agonists as a putative class of antidepressants with a rapid onset of action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785179     DOI: 10.1016/j.neuron.2007.07.041

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  95 in total

1.  5-HT(2B) receptors are required for serotonin-selective antidepressant actions.

Authors:  S L Diaz; S Doly; N Narboux-Nême; S Fernández; P Mazot; S M Banas; K Boutourlinsky; I Moutkine; A Belmer; A Roumier; L Maroteaux
Journal:  Mol Psychiatry       Date:  2011-12-13       Impact factor: 15.992

2.  Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.

Authors:  Cédric Lecoutey; Damien Hedou; Thomas Freret; Patrizia Giannoni; Florence Gaven; Marc Since; Valentine Bouet; Céline Ballandonne; Sophie Corvaisier; Aurélie Malzert Fréon; Serge Mignani; Thierry Cresteil; Michel Boulouard; Sylvie Claeysen; Christophe Rochais; Patrick Dallemagne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

3.  Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo.

Authors:  Kirsten X Jacobsen; Margaret Czesak; Mariam Deria; Brice Le François; Paul R Albert
Journal:  J Neurochem       Date:  2011-01-24       Impact factor: 5.372

Review 4.  Neurogenesis and exercise: past and future directions.

Authors:  Henriette van Praag
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

5.  Cell cycle regulation, neurogenesis, and depression.

Authors:  Kathryn A Cunningham; Cheryl S Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

Review 6.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

7.  Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism.

Authors:  Indira Mendez-David; Denis J David; Flavie Darcet; Melody V Wu; Saadia Kerdine-Römer; Alain M Gardier; René Hen
Journal:  Neuropsychopharmacology       Date:  2013-11-28       Impact factor: 7.853

Review 8.  Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.

Authors:  Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David
Journal:  Neuroscientist       Date:  2014-12-08       Impact factor: 7.519

9.  Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Authors:  Cedric Mombereau; Tamar L Gur; Jennifer Onksen; Julie A Blendy
Journal:  Int J Neuropsychopharmacol       Date:  2009-12-14       Impact factor: 5.176

10.  A novel regulator of angiogenesis in endothelial cells: 5-hydroxytriptamine 4 receptor.

Authors:  Jasmina Profirovic; Elena Strekalova; Norifumi Urao; Aleksandar Krbanjevic; Alexandra V Andreeva; Sudhahar Varadarajan; Tohru Fukai; René Hen; Masuko Ushio-Fukai; Tatyana A Voyno-Yasenetskaya
Journal:  Angiogenesis       Date:  2012-08-18       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.